Bain Capital Life Sciences Investors as of June 30, 2020
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 15 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 32.0 | $306M | 7.3M | 42.00 | |
| Arcutis Biotherapeutics (ARQT) | 12.6 | $120M | 4.0M | 30.24 | |
| Dicerna Pharmaceuticals | 10.9 | $104M | 4.1M | 25.40 | |
| Dynavax Technologies (DVAX) | 10.1 | $97M | 11M | 8.87 | |
| Mersana Therapeutics (MRSN) | 8.4 | $81M | 3.4M | 23.40 | |
| Replimune Group (REPL) | 5.6 | $54M | 2.2M | 24.85 | |
| Constellation Pharmceticls I | 4.4 | $42M | 1.4M | 30.05 | |
| Aeglea Biotherapeutics | 2.6 | $25M | 2.7M | 9.25 | |
| Aptinyx | 2.4 | $23M | 5.6M | 4.17 | |
| Savara (SVRA) | 2.4 | $23M | 5.1M | 4.48 | |
| Sage Therapeutics (SAGE) | 2.2 | $21M | 499k | 41.58 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.0 | $19M | 1.1M | 17.52 | |
| X4 Pharmaceuticals (XFOR) | 1.6 | $15M | 1.6M | 9.32 | |
| Marinus Pharmaceuticals | 1.5 | $15M | 5.7M | 2.54 | |
| Solid Biosciences | 1.2 | $11M | 3.9M | 2.93 |
